CLINICAL_TRIALS
trial_result
· 2021-03-09
Clinical Trial Update: A Study of Pembrolizumab in Patients With Neuroendocrine Tumors [Phase 2]
Summary
Phase 2 trial of pembrolizumab in patients with neuroendocrine tumors has completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fox Chase Cancer Center | Conditions: Neuroendocrine Tumors | Phase 2 | Status: COMPLETED | Results posted: 2021-03-09